146P The dynamics between neo-adjuvant treatment and immune responses in human breast cancer

ConclusionNAT provokes changes in immune activities at the tumor site in early BC, with some of these alterations apparently linked to specific treatments. Our ongoing efforts are designed to provide detailed insight into the alterations associated with different NAT modalities and define prognostic biomarkers.Legal entity responsible for the studyThe authors.FundingFRNS, T élévie, Les Amis de l'Institut Bordet, Lambeau Marteau.DisclosureA. Pabois: Full / Part-time employment: Iteos therapeutics. All other authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research